Preclinical Studies are executed to test a medical device in animals before conducting any clinical trials in the patient to verify biological safety and effectiveness of the medical device. Biocompatibility testing and risk assessment for marketing approval of medical devices necessarily entails accurate analysis of data from biological evaluation and animal testing. Therefore, the newly-organized preclinical team is attracting expectations to enhance the competitiveness of the product while improving the safety in medical procedures.

The new preclinical team provides expert research support services to various medical personnel and researchers, not to mention supporting Taewoong’s own products in development. The team has already been entrusted with animal tissue with biomaterial implant from several universities and research institutions and has embarked on the histological analysis service.

For those researchers who require animal experiments will benefit from a laboratory animal center of Osong Medical device development center (Department of evaluation Bio Compatibility assessment team; www.kiobhealth.kr). A researcher-centered ‘One-way system’ embracing from the whole process of animal testing to histological analysis will be introduced in the near future. In addition, to aid the safe and correct use of commercial products, the domestic and international sales divisions are preparing to implement training programs using experimental animals targeted for medical specialists.

With the installation of the new preclinical team, Taewoong Medical can internally evaluate cell testing and animal testing from early stages of development to the point of completing a new product, which will enable Taewoong to introduce mature products to the market in a much shorter period of time. Also, offering targeted training programs to medical specialists and histological analysis service will enhance efficiency and research achievements of medical devices.